Yount has studied flu and this protein for years, and his lab developed a mouse model lacking the gene that codes for IFITM3—making the animals highly susceptible to flu. In this new work, his ...

NEWTON, PA — Traws Pharma, Inc. (NASDAQ: TRAW) is set to host a virtual investor event on Monday, March 31, 2025, at 10:00 AM ...

Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two ...

is a molecule that alerts the body's immune system to attack not only swine flu but also bird flu. They tested the vaccine on mice, where it worked well. It didn't work quite as well on monkeys ...

Eradivir, a clinical-stage small molecule immunotherapy biotech company ... These studies have also shown EV25's ability to treat several flu strains, including pandemic strains and those ...

Traws Pharma (TRAW) announced topline results from a study evaluating the use of tivoxavir marboxil as a treatment for non-human primates ...

The viral respiratory disease program includes two novel, Phase 1, potentially best-in-class, small molecule drug candidates: tivoxavir marboxil, in development for bird flu and seasonal influenza ...

The viral respiratory disease program includes two novel, Phase 1, potentially best-in-class, small molecule drug candidates: tivoxavir marboxil, in development for bird flu and seasonal influenza, ...